488 related articles for article (PubMed ID: 22365777)
1. Adeno-associated virus vectorology, manufacturing, and clinical applications.
Grieger JC; Samulski RJ
Methods Enzymol; 2012; 507():229-54. PubMed ID: 22365777
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
Grieger JC; Samulski RJ
Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
[TBL] [Abstract][Full Text] [Related]
3. AAV vectors for hemophilia B gene therapy.
Chao H; Walsh CE
Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431
[TBL] [Abstract][Full Text] [Related]
4. Production and purification of recombinant adeno-associated vectors.
Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
[TBL] [Abstract][Full Text] [Related]
5. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
6. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
Hallek M; Wendtner CM
Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
[TBL] [Abstract][Full Text] [Related]
8. Orthopaedic gene therapy using recombinant adeno-associated virus vectors.
Ke J; Zheng LW; Cheung LK
Arch Oral Biol; 2011 Jul; 56(7):619-28. PubMed ID: 21354554
[TBL] [Abstract][Full Text] [Related]
9. Vector characterization methods for quality control testing of recombinant adeno-associated viruses.
Wright JF; Zelenaia O
Methods Mol Biol; 2011; 737():247-78. PubMed ID: 21590401
[TBL] [Abstract][Full Text] [Related]
10. Clinical gene therapy using recombinant adeno-associated virus vectors.
Mueller C; Flotte TR
Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
[TBL] [Abstract][Full Text] [Related]
11. Transduction of striatum and cortex tissues by adeno-associated viral vectors produced by herpes simplex virus- and baculovirus-based methods.
Zhang HS; Kim E; Lee S; Ahn IS; Jang JH
J Virol Methods; 2012 Jan; 179(1):276-80. PubMed ID: 22015677
[TBL] [Abstract][Full Text] [Related]
12. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
13. Current development of adeno-associated viral vectors.
Romano G
Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus: from defective virus to effective vector.
Gonçalves MA
Virol J; 2005 May; 2():43. PubMed ID: 15877812
[TBL] [Abstract][Full Text] [Related]
15. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
16. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC
Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958
[TBL] [Abstract][Full Text] [Related]
18. Manufacturing and characterizing AAV-based vectors for use in clinical studies.
Wright JF
Gene Ther; 2008 Jun; 15(11):840-8. PubMed ID: 18418418
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in adeno-associated virus vector technology.
Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
During MJ; Leone P
Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
